Ventyx Biosciences, Inc. Common Stock
VTYX Real Time Price USDRecent trades of VTYX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by VTYX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
VTYX Revenue by Segment or Geography
New patents grants
-
Patent Title: Tyk2 pseudokinase ligands Oct. 10, 2023
-
Patent Title: Substituted pyrazolo[1,5-a]pyrimidines as tyk2 pseudokinase ligands Sep. 12, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to VTYX
Number of mentions of VTYX in WallStreetBets Daily Discussion
Recent picks made for VTYX stock on CNBC
ETFs with the largest estimated holdings in VTYX
|
Shareholder
|
Shares Held
|
|---|
- Who owns $VTYX stock?
- Who owns the most shares of $VTYX stock?
- What funds own $VTYX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view VTYX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.